Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From PTSC:

From PTSC:

posted on Jan 16, 2009 11:43AM

There are currently in excess of 18,000 individual shareholders.

Company said they believe there were more than 225 on web and 55+ on phone for the CC.

Dutton was listening (as we all know) and another analyst.........don't know "who"

Just thought you'd all like to know. What a GREAT start for our first CC.

I also asked if we could find out how many HITS we're getting on the website for the CC.

I'll let everyone know "if" I find out.

Deb

Share
New Message
Please login to post a reply